10X Capital III Stock Price, News & Analysis

10X Capital Venture Acquisition Corp. III (NYSE: VCXB.U, VCXB, VCXB WS) is a blank check company sponsored by 10X Capital, an alternative asset management firm. 10X Capital leverages advancements in data analytics and AI to generate signals, deliver insights, and drive returns across various asset classes. Committed to promoting Diversity, Equity & Inclusion, 10X Capital is among the most active venture capital firms globally, aligning Wall Street, Main Street, and Silicon Valley by bringing institutional capital and strategies to high-growth ventures and income opportunities in both private and public markets.

10X Capital Venture Acquisition Corp. III, also known as 10X III, focuses on identifying high-growth businesses domestically and abroad, bringing them to public markets through special purpose acquisition. Recently, 10X III made headlines by transferring the listing of its Class A ordinary shares, redeemable warrants, and units from the New York Stock Exchange to NYSE American LLC to benefit from more favorable listing thresholds.

In a noteworthy move, 10X III entered into a merger agreement with American Gene Technologies International Inc., aiming to create a publicly listed company named Addimmune. The parties intend to file relevant materials with the SEC, ensuring shareholders and potential investors have access to important information regarding the proposed business combination.

10X III recently faced compliance challenges with NYSE American's continued listing standards due to not timely filing its Quarterly Report for the quarter ending September 30, 2023. Nonetheless, the company promptly addressed the issue by filing the required report, thus regaining compliance. Additionally, 10X III was notified of not meeting the minimum shareholder requirement but plans to submit a compliance plan by February 28, 2024, to resolve this deficiency.

For more information and the latest updates, visit 10X III's official website or contact their investor relations at ir@10xcapital.com.